How to Cite this Article: DeScipio C, Conlin L, Rosenfeld J, Tepperberg J, Pasion R, Patel A, McDonald MT, Aradhya S, Ho D, Goldstein J, McGuire M, Mulchandani S, Medne L, Rupps R, Serrano AH, Thorland EC, Tsai AC-H, Hilhorst-Hofstee Y, Ruivenkamp CAL, Van Esch H, Addor M-C, Martinet D, Mason TBA, Clark D, Spinner NB, Krantz ID. 2012. Subtelomeric deletion of chromosome 10p15.3: Clinical findings and molecular cytogenetic characterization. Am J Med Genet Part A. 158A:2152–2161.
Subtelomeric deletion of chromosome 10p15.3: Clinical findings and molecular cytogenetic characterization†
Version of Record online: 27 JUL 2012
Copyright © 2012 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part A
Volume 158A, Issue 9, pages 2152–2161, September 2012
How to Cite
DeScipio, C., Conlin, L., Rosenfeld, J., Tepperberg, J., Pasion, R., Patel, A., McDonald, M. T., Aradhya, S., Ho, D., Goldstein, J., McGuire, M., Mulchandani, S., Medne, L., Rupps, R., Serrano, A. H., Thorland, E. C., Tsai, A. C.-H., Hilhorst-Hofstee, Y., Ruivenkamp, C. A.L., Van Esch, H., Addor, M.-C., Martinet, D., Mason, T. B.A., Clark, D., Spinner, N. B. and Krantz, I. D. (2012), Subtelomeric deletion of chromosome 10p15.3: Clinical findings and molecular cytogenetic characterization. Am. J. Med. Genet., 158A: 2152–2161. doi: 10.1002/ajmg.a.35574
- Issue online: 24 AUG 2012
- Version of Record online: 27 JUL 2012
- Manuscript Accepted: 28 JUN 2012
- Manuscript Received: 30 DEC 2011
- National Institutes of Health (NIDDK) (IDK). Grant Number: 5 KO8 DK02541-02
- Wellcome Trust
- chromosomal microarray (CMA);
We describe 19 unrelated individuals with submicroscopic deletions involving 10p15.3 characterized by chromosomal microarray (CMA). Interestingly, to our knowledge, only two individuals with isolated, submicroscopic 10p15.3 deletion have been reported to date; however, only limited clinical information is available for these probands and the deleted region has not been molecularly mapped. Comprehensive clinical history was obtained for 12 of the 19 individuals described in this study. Common features among these 12 individuals include: cognitive/behavioral/developmental differences (11/11), speech delay/language disorder (10/10), motor delay (10/10), craniofacial dysmorphism (9/12), hypotonia (7/11), brain anomalies (4/6) and seizures (3/7). Parental studies were performed for nine of the 19 individuals; the 10p15.3 deletion was de novo in seven of the probands, not maternally inherited in one proband and inherited from an apparently affected mother in one proband. Molecular mapping of the 19 individuals reported in this study has identified two genes, ZMYND11 (OMIM 608668) and DIP2C (OMIM 611380; UCSC Genome Browser), mapping within 10p15.3 which are most commonly deleted. Although no single gene has been identified which is deleted in all 19 individuals studied, the deleted region in all but one individual includes ZMYND11 and the deleted region in all but one other individual includes DIP2C. There is not a clearly identifiable phenotypic difference between these two individuals and the size of the deleted region does not generally predict clinical features. Little is currently known about these genes complicating a direct genotype/phenotype correlation at this time. These data however, suggest that ZMYND11 and/or DIP2C haploinsufficiency contributes to the clinical features associated with 10p15 deletions in probands described in this study. © 2012 Wiley Periodicals, Inc.